The UK has also got 1,000 personnel ready to support humanitarian responses, if required.
SiteIQ platform will offer insights on clinical research site experience, capacity, quality and performance among others.
The trial will evaluate the combination of BI 1701963 and Lumakras (sotorasib) in patients with lung and colorectal cancers.
The study will evaluate the safety, tolerability, cell kinetics and anti-tumour activity of NTLA-5001 in adults with AML.
The platform will help in accelerating clinical trials with deep learning-based image analysis.
Give your business an edge with our leading industry insights.
Triall will leverage LTO Network’s blockchain technology and infrastructure to anchor the research data.
The trial tested the safety and efficacy of Jardiance in patients with chronic HFpEF.
ANAVEX 2-73 slowed the progression of motor and non-motor symptoms in moderately advanced patients with Parkinson’s disease.
The failure also prompted Polyphor to carry out a strategic assessment about the future of the company.
The study plans to enrol around 14,000 patients who are at high risk of recurrent acute myocardial infarction (AMI).